Vitamin E Can Fight Cancer, But Dietary Vitamin E Doesn't Do the Trick
March 26, 2013 8:50 AM
Study suggests special Vitamin E-derived drug will be most effective
is a vitamin used by the human body for
a variety of purposes
. Composed of two groups of fused aromatic rings and a fatty tail, the vitamin commonly occurs in two varieties -- beta and gamma-Tocopherols. Now a new study by
Ohio State University
suggests that vitamin E -- or synthetic analogues -- may be useful in fighting a
broad spectrum of cancers
I. Vitamin E Variants Can Fight Cancer
The new study by
, professor of
medicinal chemistry and pharmacognos
y at The Ohio State University and an investigator in
Ohio State’s Comprehensive Cancer Center
, first examined Vitamin E's role in suppressing
, an enzyme that helps keep cancer cells alive.
, "This is the first demonstration of a unique mechanism of how vitamin E can have some benefit in terms of cancer prevention and treatment."
Akt is associated with keeping a variety of cancer cells alive. It is common in many common cancerous cell types with
gene mutations -- such as prostate cancers. The excess Akt suppress apoptosis (cell death) granting the dangerous cells immortality. But suppressing Akt allows the body's natural processes to trigger death of the tumor cells.
Before you rush to load up on Vitamin E pills beware -- the pills contain mostly alpha and beta-Tocopherols, forms of Vitamin E, which the study found to be less effective in suppressing Akt. By contrast, the gamma form is generally poorly absorbed from dietary supplements and scarcer in pill formulations.
Vitamin E and its derivatives are most effective in fighting cancer.
[Image Source: Wikimedia Commons]
Researchers discovered that by tweaking the structure of the more effective gamma variant -- shortening the fatty acid side chain -- they could get an even more impressive 20-fold increase in Akt suppression.
II. Mechanism of Action Identified, OSU Patents Drug
The researchers explain that the effect occurs when Vitamin E binds to Akt and sequesters it to the fatty lipid bilayer on the cell's inner surface. The complex then attracts
, an anti-tumor agent that binds and inactivates Akt. Professor Chen explains, "This is a new finding. We have been taking vitamin E for years but nobody really knew about this particular anti-cancer mechanism. By reducing two-thirds of the chain, the molecule had a 20 times more potent anti-tumor effect, while retaining the integrity of vitamin E’s head group."
Rodents injected with the Vitamin E-like chemical saw death of prostate cancer tumors, saving their lives. At the same time the agent showed no toxicity or other adverse effects.
AKT1 (left) and AKT2 (right) are common cancer-causing proteins, which the Vitamin E derivatives block. [Image Source: Wikimedia Commons]
While dietary vitamin E is crucial for other purposes, the successful tumor-killing properties of the vitamin E derivative could lead to a new non-toxic cancer therapy via either injections of the drug or ingested absorption. Describes Professor Chen, "Our goal is to develop a safe pill at the right dose that people could take every day for cancer prevention. It takes time to optimize the formulation and the dose."
Ohio State has patented the Vitamin-E derived chemical, indicating that it hopes to commercialize it as a cancer treatment.
The work was funded by government grants from the
National Institutes of Health
, and a paper on the work was
in this month's issue of the peer-reviewed journal
Ohio State Univ.
"There's no chance that the iPhone is going to get any significant market share. No chance." -- Microsoft CEO Steve Ballmer
Human Skin Cells Used to Create Stem Cells, Treat Brain Disease in Mice
February 8, 2013, 1:25 PM
Scientists Feed Vitamins to Bacteria to Increase Electrical Output
March 4, 2008, 3:20 PM
Biotech, Genetic Engineering and the Boy Who Cried Wolf
September 5, 2007, 11:55 AM
PIQ ROBOTTM reveals its new artificial intelligence software
November 29, 2016, 12:59 AM
One more time - Happy Thanksgiving to Everyone Around the World
November 24, 2016, 4:00 AM
Google’s Smart Contact Lens Project gets halted for 2016
November 20, 2016, 7:00 AM
Cell Research Study shows African Americans have greater immune response to infection
November 10, 2016, 1:00 AM
UTHealth Clinical Trial Shows Progress Using Stem Cells to Treat Traumatic Brain Injury
November 8, 2016, 1:00 AM
Uber Partners with Circulation to Pilot Program Connecting Transportation and Digital Health Care
November 6, 2016, 5:00 AM
Most Popular Articles
Kobo Aura One Vs Kindle Paperwhite
January 10, 2017, 1:21 AM
New at CES 2017 - Changhong 8K Super Slim TV 65ZHQ3R
January 8, 2017, 1:07 AM
OPPO R9 – The Smartphone with Excellent Camera and Long Battery Life
January 12, 2017, 12:01 AM
Are you in the market for a private antenna?
January 11, 2017, 12:01 AM
Comparison: Xiaomi Mi Mix Vs. HTC U Ultra
January 14, 2017, 12:10 AM
Latest Blog Posts
Jan 17, 2017, 12:16 AM
News of the Day
Jan 16, 2017, 12:10 PM
News and Technology Advancement
Jan 16, 2017, 7:58 AM
Jan 15, 2017, 12:32 AM
Here is Some News
Jan 14, 2017, 12:39 AM
News: Improved and New products
Jan 13, 2017, 12:01 AM
News around the world
Jan 12, 2017, 12:01 AM
Rumors and Announcements
Jan 11, 2017, 12:01 AM
This year CES and ridiculous gadgets
Jan 10, 2017, 12:01 AM
Nokia Android phone spurns the west.
Jan 9, 2017, 12:08 AM
New at CES 2017 - Changhong 8K Super Slim TV 65ZHQ3R
Jan 8, 2017, 1:07 AM
Debuted at CES 2017 - Vuzix Blade 3000 Smart Sunglasses
Jan 8, 2017, 12:39 AM
Some news of Day
Jan 7, 2017, 12:01 AM
News 2017 CES
Jan 6, 2017, 12:01 AM
Here is the Latest News in Tech
Jan 5, 2017, 1:47 AM
AI Beats World’s Best at Chinese board game “Go”
Jan 4, 2017, 11:21 AM
Las Vegas 2017 CES
Jan 3, 2017, 12:01 AM
News of Jan 2nd 2017
Jan 2, 2017, 4:40 AM
Wishing you all, the New Year brings the light of hope, joy, success, and Happy, Happy New Year.
Jan 1, 2017, 1:48 AM
More Blog Posts
Copyright 2017 DailyTech LLC. -
Terms, Conditions & Privacy Information